BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2571072)

  • 21. Identification of a distinct class of vinblastine binding sites on microtubules.
    Jordan MA; Margolis RL; Himes RH; Wilson L
    J Mol Biol; 1986 Jan; 187(1):61-73. PubMed ID: 3959083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhazinilam mimics the cellular effects of taxol by different mechanisms of action.
    David B; Sévenet T; Morgat M; Guénard G; Moisand A; Tollon Y; Thoison O; Wright M
    Cell Motil Cytoskeleton; 1994; 28(4):317-26. PubMed ID: 7954858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taxol binds to polymerized tubulin in vitro.
    Parness J; Horwitz SB
    J Cell Biol; 1981 Nov; 91(2 Pt 1):479-87. PubMed ID: 6118377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro studies on the role of HMW-MAPs in taxol-induced microtubule bundling.
    Albertini DF; Herman B; Sherline P
    Eur J Cell Biol; 1984 Jan; 33(1):134-43. PubMed ID: 6141942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estramustine depolymerizes microtubules by binding to tubulin.
    Dahllöf B; Billström A; Cabral F; Hartley-Asp B
    Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics.
    Downing KH
    Annu Rev Cell Dev Biol; 2000; 16():89-111. PubMed ID: 11031231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules.
    Himes RH
    Pharmacol Ther; 1991; 51(2):257-67. PubMed ID: 1784631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.
    Wilson L; Panda D; Jordan MA
    Cell Struct Funct; 1999 Oct; 24(5):329-35. PubMed ID: 15216890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystallographic structure of tubulin: implications for dynamics and drug binding.
    Downing KH; Nogales E
    Cell Struct Funct; 1999 Oct; 24(5):269-75. PubMed ID: 15216882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microtubules as drug receptors: pharmacological properties of microtubule protein.
    Wilson L
    Ann N Y Acad Sci; 1975 Jun; 253():213-31. PubMed ID: 1096718
    [No Abstract]   [Full Text] [Related]  

  • 31. Taxol: an antimitotic agent with a new mechanism of action.
    Manfredi JJ; Horwitz SB
    Pharmacol Ther; 1984; 25(1):83-125. PubMed ID: 6149569
    [No Abstract]   [Full Text] [Related]  

  • 32. Tubulin degradation: Principles, agents, and applications.
    Zhang YF; Huang J; Zhang WX; Liu YH; Wang X; Song J; Jin CY; Zhang SY
    Bioorg Chem; 2023 Oct; 139():106684. PubMed ID: 37356337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When Taxol met tubulin.
    Arnst J
    J Biol Chem; 2020 Oct; 295(41):13994-13995. PubMed ID: 33037081
    [No Abstract]   [Full Text] [Related]  

  • 34. Binding of vinblastine to stabilized microtubules.
    Singer WD; Jordan MA; Wilson L; Himes RH
    Mol Pharmacol; 1989 Sep; 36(3):366-70. PubMed ID: 2571072
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.